Clean Break: the company completely halting Russian engagements or exiting Russia

Leave Withdrawal
 

Clean Break: the company completely halting Russian engagements or exiting Russia

Leave Withdrawal
Revenue(RF), mln.USD
156
Assets(RF), mln.USD
36
Capital(RF), mln.USD
34
Glob.Revenue, mln.USD
46385
Staff(RF), 2021
123
Taxes(RF), mln.USD
26
The Company Statement
June 02, 2022

BMS is handing over its Russian commercial operations to its distribution partner Swixx Healthcare, previously known as Amicus, a Bristol spokesperson said over email

Open the Statement
Statements Archive
June 01, 2022Bristol-Myers Squibb is first foreign pharma to leave Russia
May 19, 2022American pharmaceutical giant Bristol-Myers Squibb is leaving Russia
March 15, 2022Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
Share the Company Status:
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner